PHARMACEUTICAL GENETICS AND IMMUNOLOGY facilitates the understanding and application of pharmaceutical genetics, immunology, and biotechnology principles.
Offering recorded · Fall 2026
Recent recorded grades — Spring 2024: 3.62 GPA, 80.4% A/AB (n=92 letter grades); Spring 2025: 3.37 GPA, 63.0% A/AB (n=127 letter grades); Fall 2025: 3.42 GPA, 65.2% A/AB (n=132 letter grades). Includes jointly taught sections.
PHMPRAC 650 covers vaccine-preventable diseases and the implementation of pharmacy-based immunization delivery programs.
Offering recorded · Fall 2026
Recent recorded grades — Fall 2023: 3.37 GPA, 60.2% A/AB (n=93 letter grades); Fall 2024: 3.33 GPA, 56.0% A/AB (n=125 letter grades); Fall 2025: 3.34 GPA, 58.6% A/AB (n=133 letter grades).
PHARMACOTHERAPY III covers clinical medication application and therapeutic monitoring for renal, endocrine, GI, rheumatologic, and immunologic diseases.
Offering recorded · Fall 2026
Recent recorded grades — Fall 2023: 3.37 GPA, 55.7% A/AB (n=122 letter grades); Fall 2024: 3.32 GPA, 60.6% A/AB (n=94 letter grades); Fall 2025: 3.28 GPA, 55.3% A/AB (n=94 letter grades). Includes jointly taught sections.
PHMSCI 540 covers drug development, delivery routes, and delivery systems for pharmacotherapy.
Offering recorded · Fall 2026
Recent recorded grades — Fall 2016: 2.98 GPA, 21.9% A/AB (n=146 letter grades); Fall 2023: 3.54 GPA, 82.7% A/AB (n=98 letter grades); Fall 2024: 3.65 GPA, 80.9% A/AB (n=94 letter grades). Includes jointly taught sections.